Every. Thx for the DD If you are looking at AMRN for the first time , using the data you provided ( increasing rev , declining cash burn ) with 2 scheduled interms within a yr , an over powered study ( if I'm understanding the stat folks here correctly ) and a large market opportunity if R-It succeeds .......what is the rational for at least not considering a spec buy ?
I'm buying at these levels $2.97 Not advising anyone else to do like wise . If it drops 20% from here I'll accept I mis judged and sell half. JMO Kiwi